Jiangzhong Pharmaceutical released its 2023 annual report. The company achieved total operating revenue of 4.39 billion yuan in 2023, an increase of 13.00% over the previous year; net profit attributable to shareholders of listed companies was 708 million yuan, an increase of 18.40% over the previous year.
江中药业：2023年归母净利润7.08亿元，同比增长18.40%
Jiangzhong Pharmaceutical: Net profit due to mother in 2023 was 708 million yuan, up 18.40% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.